Skip to content

Drug interactions

Dexamethasone-tobramycin + Olaparib

Severity: Moderate

Dexamethasone-tobramycin and Olaparib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Dexamethasone can induce CYP3A4 and may reduce olaparib exposure, potentially lowering its anticancer effect. The induction is weaker than that of strong inducers such as rifampin. Topical use has negligible effect.

What this interaction means in plain words

Dexamethasone-tobramycin and Olaparib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Dexamethasone-tobramycin belongs to Anti Bacterial; Olaparib belongs to Oncology.

Evidence level: Low

Why it happens

CYP3A4 induction by dexamethasone increases olaparib metabolism.

What to do

Monitor for reduced olaparib response during prolonged systemic dexamethasone therapy. Prefer a non-inducing alternative where practical.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dexamethasone-tobramycin and Olaparib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Dexamethasone-tobramycin with Olaparib?

MediHelp rates the interaction as moderate. Dexamethasone-tobramycin and Olaparib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Dexamethasone can induce CYP3A4 and may reduce olaparib exposure, potentially lowering its anticancer effect. The induction is weaker than that of strong inducers such as rifampin. Topical use has negligible effect.

How serious is the interaction between Dexamethasone-tobramycin and Olaparib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for reduced olaparib response during prolonged systemic dexamethasone therapy. Prefer a non-inducing alternative where practical.

What other medicines interact with Dexamethasone-tobramycin?

MediHelp also lists interactions of Dexamethasone-tobramycin with, for example, Capreomycin, Carboplatin, Ciprofloxacin. The full list is on the Dexamethasone-tobramycin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in